India Globalization Capital Inc
F:IGS1

Watchlist Manager
India Globalization Capital Inc Logo
India Globalization Capital Inc
F:IGS1
Watchlist
Price: 0.246 EUR 2.5% Market Closed
Market Cap: €18.6m

India Globalization Capital Inc
Investor Relations

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The company is headquartered in Potomac, Maryland and currently employs 50 full-time employees. The company went IPO on 2006-04-13. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment involves the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, among others, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment involves execution of construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ram Mukunda
President, CEO & Director
No Bio Available
Ms. Claudia Grimaldi
VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director
No Bio Available
Benysh Qureshi Esq., M.B.A.
Director of Operations
No Bio Available
Mr. Rohit Goel
Senior Director of Accounting & Principal Accounting Officer
No Bio Available

Contacts

Address
MARYLAND
Potomac
10224 Falls Road
Contacts
+13019830998.0
www.igcinc.us
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett